ArticleCell chemical biology2022

Generation of an anticoagulant aptamer that targets factor V/Va and disrupts the FVa-membrane interaction in normal and COVID-19 patient samples.

Erin E Soule et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.